New patent for Mallinckrodt Ireland drug TERLIVAZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TERLIVAZ
Annual Drug Patent Expirations for TERLIVAZ

Terlivaz is a drug marketed by Mallinckrodt Ireland and is included in one NDA. It is available from one supplier.

The generic ingredient in TERLIVAZ is terlipressin acetate. One supplier is listed for this compound. Additional details are available on the terlipressin acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top